» Articles » PMID: 36943434

A Comparison of the Efficacy and Safety Profiles of 10% Salicylic Acid and 10% Urea Creams in Treating Acanthosis Nigricans in Adolescents: a Randomized Double-blinded Study

Overview
Specialty Dermatology
Date 2023 Mar 21
PMID 36943434
Authors
Affiliations
Soon will be listed here.
Abstract

Acanthosis nigricans is characterized by the presence of velvety hyperpigmentation of the skin over the neck and the flexural areas. Regardless of different modalities of treatment, none provides a definite standard cure. This study aims to assess the efficacy of topical 10% salicylic acid compared to 10% urea cream in treating acanthosis nigricans in adolescents. A randomized comparative, double-blind study is conducted on adolescents with acanthosis nigricans of the posterior neck. Treatment efficacy was assessed via a narrowband reflectance spectrophotometer at individual follow-up visits at weeks 2, 4, and 8, while the overall success rates were evaluated by the investigator-assessed and participant-assessed global evaluation scales (IGE and PGE). Acanthosis nigricans scoring chart (ANSC) and adverse effects are also assessed. A total of 39 participants with acanthosis nigricans enrolled and completed the study. Throughout the 8-week period of treatment, the use of 10% salicylic acid demonstrated strong effectiveness in treatment with 14.6 ± 10.6% improvement, while the 10% urea demonstrated 12.5 ± 10.9% improvement. Findings from the overall global evaluation scales were consistent with the results from the narrowband reflectance spectrophotometer. Treatment with 10% salicylic and 10% urea produced no serious local skin adverse reactions. Both medications improve neck hyperpigmentation associated with acanthosis nigricans in adolescents, in which the 10% salicylic acid and 10% urea cream demonstrate similar efficacy and safety profiles. Clinical Trials Registry: TCTR20201123003.

Citing Articles

Assessing the efficacy and safety profiles of 0.025% tretinoin in treating axillary hyperpigmentation with acanthosis nigricans: a randomized double-blinded study.

Chunekamrai P, Chatpimolkul N, Thummawatwimon S, Treesirichod A Arch Dermatol Res. 2025; 317(1):297.

PMID: 39833642 DOI: 10.1007/s00403-025-03821-y.


Systematic review of topical, laser, and oral treatments in acanthosis nigricans clinical trials.

Bitterman D, Patel P, Zafar K, Wang J, Kabakova M, Gollogly J Arch Dermatol Res. 2024; 316(7):424.

PMID: 38904687 DOI: 10.1007/s00403-024-02931-3.


Correlation between Acanthosis Nigricans Scoring Chart (ANSC) and narrowband reflectance spectrophotometer in assessing severity of acanthosis nigricans.

Treesirichod A, Kritsanaviparkporn C, Sangaphunchai P, Chansakulporn S Skin Res Technol. 2023; 29(8):e13428.

PMID: 37632186 PMC: 10387586. DOI: 10.1111/srt.13428.

References
1.
Phiske M . An approach to acanthosis nigricans. Indian Dermatol Online J. 2014; 5(3):239-49. PMC: 4144206. DOI: 10.4103/2229-5178.137765. View

2.
Das A, Datta D, Kassir M, Wollina U, Galadari H, Lotti T . Acanthosis nigricans: A review. J Cosmet Dermatol. 2020; 19(8):1857-1865. DOI: 10.1111/jocd.13544. View

3.
Treesirichod A, Chaithirayanon S, Chaikul T, Chansakulporn S . The randomized trials of 10% urea cream and 0.025% tretinoin cream in the treatment of acanthosis nigricans. J Dermatolog Treat. 2019; 32(7):837-842. DOI: 10.1080/09546634.2019.1708855. View

4.
Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J . Urea: a comprehensive review of the clinical literature. Dermatol Online J. 2013; 19(11):20392. View

5.
Arif T . Salicylic acid as a peeling agent: a comprehensive review. Clin Cosmet Investig Dermatol. 2015; 8:455-61. PMC: 4554394. DOI: 10.2147/CCID.S84765. View